About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials | 7,492 Studies Recruiting

Clinical TrialsProstate Cancer

Prostate Cancer Clinical Trials

Browse 7,492 clinical trials for prostate cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 981-1000 of 7,492 trials

TerminatedTreatment Resistance Following Anti-cancer TherapiesThe TRANSLATE study aims to better understand why tumors become resistant to standard anti-cancer therapies.NCT04436120·Daphne, Alabama and 32 others

Related Searches

prostate carcinomatrials

Data from ClinicalTrials.govTerms

CompletedImproving Prostate Cancer Detection Using MRI-Targeted TRUS-Guided BiopsyThe purpose of this study is to determine if using MRI can improve cancer detection by identifying potential cancer targets prior to TRUS-guided biopsy in populations that have…NCT02488096·Regina, Saskatchewan

UnknownPSMA PET/CT vs. mpMRI in Patients With a High Suspicion of Prostate Cancer: a Head to Head, Parallel, Prospective TrialThis is prospective single-arm case-control study designed to compare in parallel PSMA PET/TRUS (trans-rectal or trans-perineal) fusion biopsy ("experimental test") with…NCT05297162·Rozzano

CompletedImpact on Quality of Life and Health of the CONTINUUM+ CONNECT Remote Monitoring SolutionFEGALA is a comparative, multicenter, randomized, prospective, open-label study comparing the results observed at 3 months (± 15 days) on the EORTC QLQ-C30 scale in a group of…NCT06379880·Vandœuvre-lès-Nancy, De and 12 others

CompletedPercutaneous High-dose Radiotherapy in Patients With Oligometastases of Prostate CarcinomaThe purpose of this study is to evaluate the outcomes of patients treated with an high dose radiation regimen using either stereotactic hypofractionated or normofractionated…NCT02264379·Dresden, Saxony and 1 other

RecruitingEffects of Rectal Indomethacin Suppository on Postoperative CRBD in Patients Undergoing LRPThe postoperative incidence of catheter-related bladder discomfort (CRBD) ranges from 47% to 95%. It increases postoperative pain and agitation, thus requiring early intervention.NCT07607990·Hangzhou, Zhejiang

CompletedPhysical Function During ARSI TreatmentThis single arm observational pilot study aims to determine the longitudinal effects of androgen receptor signaling inhibitors (ARSI) in men with advanced prostate cancer.NCT05612880·Chapel Hill, North Carolina

RecruitingA Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer DrugsANDROMEDA is a first-in-human, Phase I/II, open-label, multicenter study of AZD9750 in participants with metastatic prostate cancer.NCT07336446·Duarte, California and 17 others

CompletedFeasibility Study Testing a Sleep Intervention in Prostate Cancer Patients With InsomniaThis study of a randomized controlled trial aims to evaluate the feasibility of a 12-week sleep program and the randomized controlled trial research procedure.NCT03444532·Næstved

CompletedNon-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate CancerThe purpose of this study is to see whether immunotherapy with BMS-986218 added to degarelix (which suppresses testosterone) given prior to surgery can decrease the chance that…NCT04301414·New York, New York

RecruitingProstate Tissue BioBankProstate cancer is also the most common cancer in men with inherited pathogenic variants in BRCA1 and BRCA2.NCT06659614·Philadelphia, Pennsylvania

CompletedErythropoietin to Enhance Recovery of Erectile Function in Men Following Radical ProstatectomyThis research study aims to explore the effectiveness of human erythropoietin versus placebo in promoting the recovery of erectile function in patients undergoing bilateral…NCT00737893·Baltimore, Maryland

CompletedLenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)The goal of this clinical research study is to find the highest tolerable doses of the combinations of lenalidomide and other drugs that can be given to patients with advanced…NCT01183663·Houston, Texas

TerminatedSafety and Activity Study of PSCA-Targeted CAR-T Cells (BPX-601) in Subjects With Selected Advanced Solid TumorsThe purpose of this study is to evaluate the safety and activity of BPX-601 CAR-T cells in participants with previously treated advanced solid tumors (prostate) expressing high…NCT02744287·Tampa, Florida and 12 others

UnknownTransperineal Laser Ablation for Low- and Intermediate Risk Prostate Cancer: a Single Cohort AnalysisThe goal of this prospective study is to test the efficacy of Echolaser transperineal focal therapy in patients with low- and intermediate risk prostate cancer.NCT05584787·Roma, RM

CompletedDecision Aids to Improve Knowledge in Patients With Prostate CancerThis randomized phase III trial studies how well decision aids work in improving knowledge in patients with prostate cancer.NCT03182998·Anchorage, Alaska and 4 others

RecruitingCancer Survivors ProgramThe questionnaire for assessment of adverse events after completion of cancer treatment, which is being piloted at the Masaryk Memorial Cancer Institute, aims to detect a wide…NCT07253987·Brno

RecruitingEvaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate CancerThe investigators are conducting this study with men that have prostate cancer and are getting standard of care treatment with the drugs abiraterone acetate and prednisone.NCT03833921·Houston, Texas and 2 others

UnknownsEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate CancerThe purpose of this phase II, single-arm, open-label, three center study is to evaluate the efficacy, safety, and tolerability of sEphB4-HSA in patients with mCRPC (metastatic…NCT04033432·Los Angeles, California and 2 others

UnknownStudy of Anti-PSMA CAR NK Cell (TABP EIC) in Metastatic Castration-Resistant Prostate CancerThe purpose of this study is to evaluate the safety, tolerability and preliminary efficacy of TABP EIC in patients with Metastatic castration-resistant prostate cancer.NCT03692663·Tianjin

PreviousPage 50 of 375Next